Hussman Strategic Advisors, Inc. Ani Pharmaceuticals Inc Transaction History

Hussman Strategic Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$58.53 - $68.82 $614,565 - $722,609	10,500 Added 33.33%	42,000 $2.67 Million
Q1 2024 May 01, 2024	BUY	$54.2 - $69.69 $1.71 Million - $2.2 Million	31,500 New	31,500 $2.18 Million
Q3 2021 Nov 01, 2021	SELL	$26.48 - $35.99 $804,992 - $1.09 Million	-30,400 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$23.69 - $31.47 $120,819 - $160,497	-5,100 Reduced 14.37%	30,400 $883,000
Q3 2019 Oct 31, 2019	BUY	$64.7 - $85.39 $679,350 - $896,595	10,500 Added 42.0%	35,500 $2.59 Million
Q2 2019 Jul 31, 2019	BUY	$67.77 - $82.2 $779,355 - $945,300	11,500 Added 85.19%	25,000 $2.06 Million
Q1 2019 May 01, 2019	SELL	$45.83 - $70.54 $160,405 - $246,890	-3,500 Reduced 20.59%	13,500 $952,000
Q3 2018 Oct 31, 2018	BUY	$52.95 - $71.34 $900,150 - $1.21 Million	17,000 New	17,000 $961,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $973M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.